{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:16:06Z","timestamp":1792062966722,"version":"4.4.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been presented to be a prognostic indicator in several cancers. We were supposed to evaluate the prognostic role of such inflammatory markers in hepatoblastoma (HB).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Total of 101 children, diagnosed with hepatoblastoma between January 2010 and January 2018, were enrolled before treatment in the study. The clinicopathological parameters, and outcomes were collected through laboratory analyses and patient follow-up. The association between NLR, PLR, and clinicopathological characters were analyzed with Wilcoxon test, Chi-Squared test, Kaplan-Meier, Log-rank and Cox regression analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>NLR and PLR were significantly elevated in HB patients (<jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001), and related to age (<jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001), risk stratification system (<jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001), and pretreatment extent of disease (<jats:italic>P\u2009<\/jats:italic>&amp;lt;\u20090.0001). NLR was significantly related to alpha-fetoprotein (<jats:italic>P<\/jats:italic>\u2009=\u20090.034) and lactate dehydrogenase (<jats:italic>P<\/jats:italic>\u2009=\u20090.026). The 3-year overall survival (OS) and event-free survival (EFS) were poor in the high-NLR group (OS: 44.3% vs. 90.3%, <jats:italic>P\u2009<\/jats:italic>&amp;lt;\u20090.0001, EFS: 38.6% vs. 80.6%, <jats:italic>P<\/jats:italic>\u2009=\u20090.0001). The 3-year OS and EFS were poor in the high-PLR group (OS: 49.1% vs. 68.8%, <jats:italic>P<\/jats:italic>\u2009=\u20090.016, EFS: 39.6% vs. 64.6%, <jats:italic>P<\/jats:italic>\u2009=\u20090.0117). The multivariate analysis suggested that NLR (HR: 11.359, 95% CI: 1.218\u2013105.947; <jats:italic>P<\/jats:italic>\u2009=\u20090.033) and risk stratification (HR: 44.905, 95% CI: 2.458\u2013820.36; <jats:italic>P<\/jats:italic>\u2009=\u20090.01), were independent predictors of OS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our research showed that elevated NLR and PLR were the poor prognostic factors in HB patients before treatment. The NLR was an independent prognostic factor for OS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2023.904730","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T04:53:37Z","timestamp":1681275217000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Tan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/hpb.12112","article-title":"Predictors of survival and incidence of hepatoblastoma in the paediatric population","volume":"15","author":"Allan","year":"2013","journal-title":"HPB"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s11912-022-01230-2","article-title":"Current approaches in hepatoblastoma-new biological insights to inform therapy","volume":"24","author":"Wu","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.21037\/atm.2019.09.76","article-title":"Survival and analysis of prognostic factors for hepatoblastoma: based on SEER database","volume":"7","author":"Feng","year":"2019","journal-title":"Ann Transl Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.jpedsurg.2011.11.073","article-title":"Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years","volume":"47","author":"Ismail","year":"2012","journal-title":"J Pediatr Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1158\/1078-0432.CCR-06-2363","article-title":"FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis","volume":"13","author":"Kobayashi","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/1471-2407-13-350","article-title":"Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy","volume":"13","author":"Lee","year":"2013","journal-title":"BMC Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s10147-014-0672-8","article-title":"Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?","volume":"20","author":"Dirican","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.suronc.2013.12.001","article-title":"A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours","volume":"23","author":"Paramanathan","year":"2014","journal-title":"Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1477-7819-12-58","article-title":"Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma","volume":"12","author":"Feng","year":"2014","journal-title":"World J Surg Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1245\/s10434-015-4518-z","article-title":"The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: which is better as a prognostic factor in gastric cancer?","volume":"22","author":"Kim","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/HMER.S89997","article-title":"Unresectable hepatoblastoma: current perspectives","volume":"9","author":"Trobaugh-Lotrario","year":"2017","journal-title":"Hepat Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1053\/j.sempedsurg.2005.11.004","article-title":"Management of liver tumors in childhood","volume":"15","author":"von Schweinitz","year":"2006","journal-title":"Semin Pediatr Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1002\/sim.4509","article-title":"Classification accuracy and cut point selection","volume":"31","author":"Liu","year":"2012","journal-title":"Stat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.ejca.2011.12.011","article-title":"Prognostic stratification for children with hepatoblastoma: the SIOPEL experience","volume":"48","author":"Maibach","year":"2012","journal-title":"Eur J Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.7314\/APJCP.2015.16.9.3997","article-title":"Assessment of prognostic value of \u201cneutrophil to lymphocyte ratio\u201d and \u201cprognostic nutritional Index\u201d as a sytemic inflammatory marker in non-small cell lung cancer","volume":"16","author":"Kos","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/ejso.2002.1257","article-title":"Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma","volume":"28","author":"Nozoe","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/bjc.2012.92","article-title":"A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)","volume":"106","author":"Pinato","year":"2012","journal-title":"Br J Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"728","DOI":"10.7314\/apjcp.2013.14.9.5473","article-title":"Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer","volume":"18","author":"Yildirim","year":"2013","journal-title":"J BUON"},{"key":"B21","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/sj.bjc.6602419","article-title":"The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer","volume":"92","author":"Canna","year":"2005","journal-title":"Br J Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/ijlh.12084","article-title":"Platelets: bridging hemostasis, inflammation, and immunity","volume":"35","author":"Jenne","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e26125","DOI":"10.1371\/journal.pone.0026125","article-title":"Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells","volume":"6","author":"Egan","year":"2011","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00006676-200408000-00008","article-title":"The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents","volume":"29","author":"Suzuki","year":"2004","journal-title":"Pancreas"},{"key":"B26","doi-asserted-by":"publisher","first-page":"E3053","DOI":"10.1073\/pnas.1411082111","article-title":"Platelets guide the formation of early metastatic niches","volume":"111","author":"Labelle","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"983698","DOI":"10.1155\/2015\/983698","article-title":"Neutrophils in cancer: two sides of the same coin","volume":"2015","author":"Uribe-Querol","year":"2015","journal-title":"J Immunol Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.31557\/APJCP.2019.20.3.863","article-title":"Pretreatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as a predictive value of hematological markers in cervical cancer","volume":"20","author":"Prabawa","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12957-016-0889-2","article-title":"Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma","volume":"14","author":"Xia","year":"2016","journal-title":"World J Surg Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12032-014-0239-6","article-title":"Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor","volume":"31","author":"Neofytou","year":"2014","journal-title":"Med Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the children's hepatic tumors international collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","article-title":"Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the international society of paediatric oncology\u2013SIOPEL 2","volume":"40","author":"Perilongo","year":"2004","journal-title":"Eur J Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00247-006-0361-5","article-title":"2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group","volume":"37","author":"Roebuck","year":"2007","journal-title":"Pediatr Radiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/omi.2010.0085","article-title":"Identification of novel prognostic markers in relapsing localized resectable neuroblastoma","volume":"15","author":"Parodi","year":"2011","journal-title":"OMICS"},{"key":"B35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4174\/jkss.2011.81.2.134","article-title":"Hepatoblastoma: 15-year experience and role of surgical treatment","volume":"81","author":"Moon","year":"2011","journal-title":"J Korean Surg Soc"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/bjc.2015.61","article-title":"Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer","volume":"112","author":"Chen","year":"2015","journal-title":"Br J Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3760\/cma.j.issn.1671-0274.2016.05.011","article-title":"Prognostic value of preoperative neutrophil-to-lymphocyte ratio in the elderly patients over 75 years old with gastric cancer","volume":"19","author":"Zhang","year":"2016","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00247-014-3000-6","article-title":"Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging","volume":"44","author":"Rojas","year":"2014","journal-title":"Pediatr Radiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00441-018-2821-2","article-title":"Neuroblastoma: clinical and biological approach to risk stratification and treatment","volume":"372","author":"Tolbert","year":"2018","journal-title":"Cell Tissue Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.14694\/EdBook_AM.2014.34.215","article-title":"Risk stratification for wilms tumor: current approach and future directions","volume":"34","author":"Dome","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.904730\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T04:53:41Z","timestamp":1681275221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.904730\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":40,"alternative-id":["10.3389\/fped.2023.904730"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.904730","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"article-number":"904730"}}